http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005070606-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c999fee6428152a996011d506925c2d7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 2004-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d82d053a35cfb3e90f45e8df123954b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39757e8915c7eb7af39f9a877583dfa9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f98454fc836989fc2f1234ffb7c6aeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25d2a5d1979a603baf694b9b45aa8ddf
publicationDate 2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2005070606-A1
titleOfInvention Pharmaceutical agent for mitochondrial disorders
abstract The present invention provides a pharmaceutical agent (e.g., a therapeutic agent) for treatment of mitochondrial disorders, which is highly safe with minimal adverse effects. Thus, the pharmaceutical agent is extremely useful as a medical product for mitochondrial disorders. The present invention also provides a method for preventing, ameliorating and/or therapeutically treating mitochondrial disorders by administering the pharmaceutical agent of the present invention.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10357478-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9518152-B2
priorityDate 2002-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128342817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127722233
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127792735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128791547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226503015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128415257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128916092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880

Total number of triples: 61.